BYLieve Trial (Alpelisib [ALP] + Endocrine Therapy [ET]) Versus Real-World (RW) Standard of Care (SOC) in Patients (Pts) With PIK3CA-Mutated (Mut), Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) Who Progressed on Cyclin-Dependent Kinase 4/6 Inhibitor (CDKi) Therapy (Tx)
Alpelisib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: BYLieve Trial (Alpelisib [ALP] + Endocrine Therapy [ET]) Versus Real-World (RW) Standard of Care (SOC) in Patients (Pts) With PIK3CA-Mutated (Mut), Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) Who Progressed on Cyclin-Dependent Kinase 4/6 Inhibitor (CDKi) Therapy (Tx) ### Output: Alpelisib